• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双侧浆液性交界性卵巢肿瘤保留生育功能治疗后的生育结局:一项大型回顾性研究结果。

Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.

机构信息

Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, P. R. China.

Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing, P. R. China.

出版信息

Hum Reprod. 2020 Feb 29;35(2):328-339. doi: 10.1093/humrep/dez307.

DOI:10.1093/humrep/dez307
PMID:32048711
Abstract

STUDY QUESTION

What are the oncofertility outcomes of young women (≤40 years old) with bilateral serous borderline ovarian tumors (SBOTs) after fertility-sparing surgery?

SUMMARY ANSWER

Fertility preservation with the bilateral ovarian cystectomy procedure is feasible for bilateral SBOTs, with an acceptable oncological outcome and worthwhile pregnancy rates.

WHAT IS KNOWN ALREADY

Fertility-sparing approaches are becoming the standard management of young patients with unilateral SBOTs and other borderline histological subtypes. However, there is a paucity of evidence to dictate the best management in bilateral SBOTs.

STUDY DESIGN, SIZE, DURATION: This was a retrospective observational study performed at the Peking Union Medical College Hospital in Beijing, China, between January 1999 and January 2019.

PARTICIPANTS/MATERIALS, SETTING, METHODS: Ninety-four women (≤40 years old) with pathologically confirmed bilateral SBOTs were included. Following preoperative counseling, patients self-selected into one of three treatment modalities: bilateral ovarian cystectomy (n = 48), unilateral adnexectomy plus contralateral cystectomy (UAC; n = 31), and radical surgery (n = 15). Univariate and multivariate analyses were used to determine the clinical and pathological features associated with disease-free survival and reproductive outcomes.

MAIN RESULTS AND THE ROLE OF CHANCE

During the median follow-up of 64 months (range, 4-243 months), 61 patients (65%) developed relapse, including 3 (20%) in the radical group, 26 (84%) in the UAC group and 32 (67%) in the bilateral cystectomy group. In the multivariate analyses, preoperative CA-125>300 U/mL, fertility preservation and micropapillary pattern were independently associated with adverse disease-free survival (P = 0.001, 0.03 and 0.026, respectively). Fourteen patients (15%) experienced invasive recurrence, and three (3%) died of progressive disease. The micropapillary pattern was significantly associated with invasive evolution risk (P = 0.006). Of the 49 patients who attempted to conceive, 23 (47%) achieved 27 pregnancies (24 spontaneous and three after IVF-ET), resulting in 19 live births. There was no significant difference in disease-free survival (P = 0.13) or pregnancy rate (41 vs. 50%, P = 0.56) between the UAC and bilateral procedures.

LIMITATIONS, REASONS FOR CAUTION: As a retrospective study conducted in a referral center, inherent biases exist. The nonrandom allocation to treatment groups and relatively small number of patients attempt to conceive might limit the statistical power of our findings. Only 41 patients (43.6%) received complete staging during their initial surgeries, so an underestimation bias in terms of the FIGO stage and extraovarian implants might have occurred.

WIDER IMPLICATIONS OF THE FINDINGS

The ultraconservative bilateral ovarian cystectomy procedure should be proposed in bilateral SBOTs when technically feasible. Invasive evolution occurs frequently in these women, and intense follow-up and oncofertility counseling are warranted, especially for those with micropapillary patterns.

STUDY FUNDING/COMPETING INTEREST(S): No external funding was used for this study. There are no conflicts of interest to declare.

TRIAL REGISTRATION NUMBER

N/A.

摘要

研究问题

年轻女性(≤40 岁)双侧浆液性交界性卵巢肿瘤(SBOT)行保留生育功能手术后的生育力结局如何?

总结答案

对于双侧 SBOT,采用双侧卵巢囊肿切除术进行生育力保存是可行的,具有可接受的肿瘤学结局和有价值的妊娠率。

已知情况

对于单侧 SBOT 和其他交界性组织学亚型的年轻患者,保留生育力的方法已成为标准治疗方法。然而,在双侧 SBOT 中,缺乏指导最佳治疗方法的证据。

研究设计、大小和持续时间:这是一项在中国北京协和医学院医院进行的回顾性观察性研究,时间为 1999 年 1 月至 2019 年 1 月。

参与者/材料、设置、方法:共纳入 94 名经病理证实为双侧 SBOT 的女性。在术前咨询后,患者自行选择以下三种治疗方式之一:双侧卵巢囊肿切除术(n=48)、单侧附件切除术加对侧囊肿切除术(UAC;n=31)和根治性手术(n=15)。采用单变量和多变量分析来确定与无病生存和生殖结局相关的临床和病理特征。

主要结果及其机会作用

在中位随访 64 个月(范围 4-243 个月)期间,61 名患者(65%)复发,包括根治组 3 名(20%)、UAC 组 26 名(84%)和双侧囊肿切除术组 32 名(67%)。多变量分析显示,术前 CA-125>300 U/mL、生育力保存和微乳头状模式与不良无病生存独立相关(P=0.001、0.03 和 0.026)。14 名患者(15%)发生侵袭性复发,3 名(3%)因进行性疾病死亡。微乳头状模式与侵袭性演变风险显著相关(P=0.006)。在 49 名试图怀孕的患者中,23 名(47%)成功妊娠 27 次(24 次自然妊娠,3 次体外受精-胚胎移植),19 例活产。UAC 和双侧手术之间在无病生存率(P=0.13)或妊娠率(41%对 50%,P=0.56)方面无显著差异。

局限性、谨慎的原因:作为一项在转诊中心进行的回顾性研究,存在固有偏倚。治疗组的非随机分配和试图怀孕的患者数量相对较少可能限制了我们研究结果的统计效力。只有 41 名患者(43.6%)在初次手术时接受了完整分期,因此可能存在 FIGO 分期和卵巢外种植物低估的偏倚。

研究结果的更广泛意义

在技术可行的情况下,应在双侧 SBOT 中提出超保守的双侧卵巢囊肿切除术。这些女性中侵袭性演变经常发生,需要进行强烈的随访和生育力咨询,特别是对于那些具有微乳头状模式的患者。

研究资金/利益冲突:本研究无外部资金支持。不存在利益冲突。

临床试验注册号

无。

相似文献

1
Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.双侧浆液性交界性卵巢肿瘤保留生育功能治疗后的生育结局:一项大型回顾性研究结果。
Hum Reprod. 2020 Feb 29;35(2):328-339. doi: 10.1093/humrep/dez307.
2
The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.临床病理和手术因素对年轻患者(≤40 岁)交界性卵巢肿瘤复发和妊娠的影响。
BMC Cancer. 2018 Nov 21;18(1):1147. doi: 10.1186/s12885-018-4932-2.
3
Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.年轻交界性卵巢肿瘤(BOTs)患者的保留生育功能手术:单机构经验
J Ovarian Res. 2016 Mar 18;9:16. doi: 10.1186/s13048-016-0226-y.
4
Oncologic and reproductive outcomes after fertility-sparing surgery for bilateral borderline ovarian tumors: A retrospective study.保留生育功能的双侧交界性卵巢肿瘤术后的肿瘤学和生殖结局:一项回顾性研究。
Eur J Obstet Gynecol Reprod Biol. 2024 May;296:107-113. doi: 10.1016/j.ejogrb.2024.02.027. Epub 2024 Feb 15.
5
[Oncological and reproductive outcomes after fertility-sparing surgery in patients with stage Ⅱ-Ⅲ borderline ovarian tumor].[Ⅱ-Ⅲ期卵巢交界性肿瘤患者保留生育功能手术后的肿瘤学及生殖结局]
Zhonghua Fu Chan Ke Za Zhi. 2024 Sep 25;59(9):702-709. doi: 10.3760/cma.j.cn112141-20240420-00232.
6
Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.交界性卵巢肿瘤:法国 CNGOF 指南。第 2 部分。手术管理、随访、激素替代治疗、生育管理和保存。
J Gynecol Obstet Hum Reprod. 2021 Jan;50(1):101966. doi: 10.1016/j.jogoh.2020.101966. Epub 2020 Nov 2.
7
Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.119 例 I 期浆液性交界性卵巢肿瘤患者保守治疗后复发的预后因素。
Ann Oncol. 2014 Jan;25(1):166-71. doi: 10.1093/annonc/mdt430. Epub 2013 Nov 28.
8
Nomogram to predict live birth rate after fertility-sparing surgery for borderline ovarian tumours.预测卵巢交界性肿瘤保留生育功能手术后活产率的列线图
Hum Reprod. 2016 Aug;31(8):1732-7. doi: 10.1093/humrep/dew137. Epub 2016 Jun 19.
9
Fertility-sparing surgery in children and adolescents with borderline ovarian tumors: a retrospective study.儿童和青少年交界性卵巢肿瘤的保留生育功能手术:一项回顾性研究。
J Ovarian Res. 2024 May 8;17(1):96. doi: 10.1186/s13048-024-01409-0.
10
Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients.超越生育力保存:oncofertility 单位在年轻癌症患者生殖和妇科随访中的作用。
Hum Reprod. 2019 Aug 1;34(8):1462-1469. doi: 10.1093/humrep/dez108.

引用本文的文献

1
Fertility-sparing surgery versus radical surgery for micropapillary serous borderline ovarian tumours: a systematic review protocol.保留生育功能手术与激进手术治疗微乳头状浆液性交界性卵巢肿瘤:系统评价方案。
BMJ Open. 2024 Nov 12;14(11):e077503. doi: 10.1136/bmjopen-2023-077503.
2
Reproductive outcomes in women opting for fertility preservation after fertility-sparing surgery for borderline ovarian tumors.对于交界性卵巢肿瘤接受保留生育功能手术后选择生育力保存的女性的生殖结局。
Arch Gynecol Obstet. 2024 May;309(5):2143-2152. doi: 10.1007/s00404-024-07445-x. Epub 2024 Mar 17.
3
Fertility and Pregnancy Outcomes after Fertility-Sparing Surgery for Early-Stage Borderline Ovarian Tumors and Epithelial Ovarian Cancer: A Single-Center Study.
早期交界性卵巢肿瘤和上皮性卵巢癌保留生育功能手术后的生育能力及妊娠结局:一项单中心研究
Cancers (Basel). 2023 Nov 8;15(22):5327. doi: 10.3390/cancers15225327.
4
Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study.伴有复发性或卵巢外病变的卵巢浆液性交界性肿瘤:一项基于日本人群的多机构回顾性研究。
Int J Clin Oncol. 2023 Oct;28(10):1411-1420. doi: 10.1007/s10147-023-02393-z. Epub 2023 Aug 1.
5
Reproductive Results in Cancer Survivors after Fertility Sparing Management: The Need for the Standardization of Definitions.保留生育功能管理后癌症幸存者的生殖结局:定义标准化的必要性。
Cancers (Basel). 2023 Jul 11;15(14):3569. doi: 10.3390/cancers15143569.
6
Fertility preservation in women with benign gynaecological conditions.患有良性妇科疾病女性的生育力保存
Hum Reprod Open. 2023 Apr 6;2023(2):hoad012. doi: 10.1093/hropen/hoad012. eCollection 2023.
7
A Deep Learning Model System for Diagnosis and Management of Adnexal Masses.一种用于附件包块诊断与管理的深度学习模型系统。
Cancers (Basel). 2022 Oct 27;14(21):5291. doi: 10.3390/cancers14215291.
8
Prognosis and Prognostic Factors of Serous Borderline Tumor-Micropapillary Variant: Retrospective Study of 200 Patients with Long-Term Follow-Up.浆液性交界性肿瘤微乳头亚型的预后及预后因素:200例长期随访患者的回顾性研究
J Oncol. 2022 Oct 10;2022:1655422. doi: 10.1155/2022/1655422. eCollection 2022.
9
Identification of clinical and molecular features of recurrent serous borderline ovarian tumour.复发性浆液性交界性卵巢肿瘤的临床及分子特征鉴定
EClinicalMedicine. 2022 Apr 8;46:101377. doi: 10.1016/j.eclinm.2022.101377. eCollection 2022 Apr.
10
Second fertility-sparing surgery and fertility-outcomes in patients with recurrent borderline ovarian tumors.复发性交界性卵巢肿瘤患者的二次保留生育功能手术和生育结局。
Arch Gynecol Obstet. 2022 Oct;306(4):1177-1183. doi: 10.1007/s00404-022-06431-5. Epub 2022 Mar 23.